Literature DB >> 16151674

Increased arterial calcification in Paget's disease of bone.

M Laroche1, A Delmotte.   

Abstract

When examining radiographs of patients with Paget's disease of bone (PD), we often observed calcification of the aorta and iliac or femoral arteries. The processes of extraosseous calcification or mineralization are very close to the mechanisms regulating mineralization of bone tissue. The aim of our study was to quantify the number, extent (length and thickness), and type (arteriosclerotic or medial arterial calcification) of vascular calcification in patients with Paget's disease and to compare them with those of controls, in order to discover whether PD is accompanied by increased calcification. Vascular calcification was quantified on the aorta, the iliac arteries, and their branches, the femoral, gluteal, and pelvic arteries of 42 patients with Paget's disease and 36 control subjects. Of the PD subjects, 52.4% had arteriosclerotic calcification versus 30.6% of controls (P = 0.05), and 38.6% of PD patients had medial arterial calcification versus 11.1% of controls (P = 0.05). The mean length of calcification was greater in PD patients: 1.93 +/- 2.85 cm versus 0.84 +/- 1.69 cm in controls (P = 0.04). The thickness of calcification was also greater in PD patients: 1.24 +/- 1.30 mm versus 0.56 +/- 0.94 mm (P = 0.01). Patients with Paget's disease more frequently had medial arterial or arteriosclerotic calcification than controls. These calcifications were longer and thicker. Our clinical study therefore confirms that abnormal vessel wall calcification and bone remodeling in Paget's disease are probably linked, although the mechanism of this relation is as yet unexplained.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151674     DOI: 10.1007/s00223-005-0250-1

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  9 in total

1.  Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.

Authors:  Joseph L Shaker
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

Review 2.  Medial arterial calcification in diabetes and its relationship to neuropathy.

Authors:  W J Jeffcoate; L M Rasmussen; L C Hofbauer; F L Game
Journal:  Diabetologia       Date:  2009-09-12       Impact factor: 10.122

Review 3.  Paget disease: when to treat and when not to treat.

Authors:  Frederick R Singer
Journal:  Nat Rev Rheumatol       Date:  2009-08-04       Impact factor: 20.543

4.  Identification of rare genetic variants in novel loci associated with Paget's disease of bone.

Authors:  Mariejka Beauregard; Edith Gagnon; Sabrina Guay-Bélanger; Jean Morissette; Jacques P Brown; Laëtitia Michou
Journal:  Hum Genet       Date:  2013-12-27       Impact factor: 4.132

5.  Chronic Kidney Disease-Induced Vascular Calcification Impairs Bone Metabolism.

Authors:  Maria L Mace; Eva Gravesen; Anders Nordholm; Soeren Egstrand; Marya Morevati; Carsten Nielsen; Andreas Kjaer; Geert Behets; Patrick D'Haese; Klaus Olgaard; Ewa Lewin
Journal:  J Bone Miner Res       Date:  2020-12-10       Impact factor: 6.741

6.  The Calcified Vasculature in Chronic Kidney Disease Secretes Factors that Inhibit Bone Mineralization.

Authors:  Maria L Mace; Eva Gravesen; Anders Nordholm; Soeren Egstrand; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  JBMR Plus       Date:  2022-03-01

7.  Paget's disease diagnosed on bone scintigraphy: Case report and literature review.

Authors:  Avs Anil Kumar; Pg Kumar; Ms Prakash; V Tewari; H Sahni; Ak Dash
Journal:  Indian J Nucl Med       Date:  2013-04

Review 8.  New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease-Mineral and Bone Disorder.

Authors:  Maria L Mace; Søren Egstrand; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Metabolites       Date:  2021-12-07

9.  Mechanisms and clinical consequences of vascular calcification.

Authors:  Dongxing Zhu; Neil C W Mackenzie; Colin Farquharson; Vicky E Macrae
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-06       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.